Broad cellular DNA synthesis machinery

The broad cellular DNA synthesis machinery, also known as the replisome, is a sophisticated multi-protein assembly responsible for the faithful duplication of the genome during the S-phase of the cell cycle (Alberts et al., Molecular Biology of the Cell). This machinery includes essential enzymes such as DNA polymerases, which synthesize new DNA strands; helicases, which unwind the double helix; and topoisomerases, which relieve torsional strain (StatPearls, DNA Replication). Because rapid and continuous DNA replication is a hallmark of both malignant cells and many pathogens, this machinery serves as a critical target for numerous therapeutic interventions (NIH, Cancer Treatment). Drugs targeting this system include antimetabolites that deplete nucleotide precursors, direct inhibitors of DNA polymerases, and agents that stabilize topoisomerase-DNA complexes to induce lethal strand breaks. However, the high degree of conservation of these processes across all dividing human cells leads to significant side effects, such as myelosuppression and gastrointestinal distress (PubMed, Chemotherapy Toxicity). Consequently, while these targets are highly effective in slowing disease progression, their use requires careful management of systemic toxicity. Modern research continues to explore more selective ways to disrupt this machinery in diseased cells while sparing healthy tissues.

Other names

DNA replication machineryDNA replisomeDNA synthesis apparatusReplication complex

Inhibition of DNA polymerases, depletion of deoxyribonucleotide pools, induction of DNA strand breaks through topoisomerase inhibition, and formation of DNA adducts that stall replication forks.